News & Updates

Eosinophil levels do not influence outcomes with triple combo asthma inhaler
Eosinophil levels do not influence outcomes with triple combo asthma inhaler
07 Jul 2023

Treatment with fixed-dose asthma inhaler combination of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) helps improve lung function and reduce exacerbations as compared with MF/IND and fluticasone/salmeterol (FLU/SAL), regardless of baseline eosinophil levels, according to a post hoc analysis of the IRIDIUM study.

Eosinophil levels do not influence outcomes with triple combo asthma inhaler
07 Jul 2023